A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Tuberculosis
Interventions
BIOLOGICAL:
MVA85A (Tuberculosis vaccine)
Sponsor
University of Oxford